humanitarianIATI

NIHR Reducing delays in cancer care in sub-Saharan Africa

by University of BirminghamUnited Kingdom

Imported from IATI · publisher data as of May 13, 2026

Follow

0 followers

Budget

£4,030,527.81

Timeline

Nov 1, 2024 – ongoing

About this project

A UK and low-middle-income country partnership (University of Ibadan, Bayero University, African Population and Health Research Center, Kenya Medical Research Institute, University of Birmingham, University of Edinburgh, University of Warwick, University of Exeter, Georgetown University) that aims to develop and then evaluate a service change to avoid delay in receiving cancer care. This study will take place over 54 months from November 2024 - April 2029. Cancer is the second largest cause of death in Sub-Saharan Africa (SSA) and the outlook for cancer is much worse in SSA than in high-income countries, mostly because people already have late-stage, and therefore incurable, disease by the time they are diagnosed. Approximately half of the delay arises after the person has been to a clinic: it is this delay within the health sector that we will study.

Published details

View source
Published by
University of Birmingham · Academic, training and research
Countries
United Kingdom, Nigeria, Kenya, United States
Sectors
Research for prevention and control of NCDs
Implemented by
University of Ibadan, Bayero University, African Population Health Research Center, University of Warwick, University of Edinburgh, University of Exeter, Health Research Operations Kenya Limited - The Operating Vehicle for the KEMRI-Wellcome Trust Research Programme

Published by University of Birmingham to the International Aid Transparency Initiative (IATI), last updated 13 May 2026 and imported automatically. IATI identifier: GB-EDU-133784-158242.

Support NIHR Reducing delays in cancer care in sub-Saharan Africa

Donations through Solarpunk Taskforce are coming soon. Until then, follow the project to get its updates and share it with people who might help.

Updates

No updates yet.